Pharmaceutical ProductCached Profile
GM85
Active Ingredients (Generic):Unmapped
LIFETIME PROMOTIONAL SPEND
$0
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
FDA Patient Safety Profile
Dynamic safety indicators compiled from official FDA product labels.
Active Clinical Trials
Clinical studies listing this drug as an active intervention.
Validation of a New Post Image Processing Engine (S-Vue™) for the Reduction of Ionizing Radiation Dose on X-ray Examination in Pediatric Patients
COMPLETEDPhase N/ANCT03935737
Utilization of Simulated Grid (SimGrid™) Technology for the Reduction of Ionizing Radiation Dose on X-ray Examination in Obese Patients
COMPLETEDPhase N/ANCT04161924
Pre-market Verification of Portable X Ray Machines for Lung Diseases and Orthopedic Limb
COMPLETEDPhase N/ANCT06542328
Top Funded Physicians (Cumulative)
Doctors receiving the highest aggregate promotional support for this product.
No physician payment records found.
Drug Marketing Payments Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for GM85...